Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Kulke

Showing results (41-50 of 182) with videos related to

Pageof 19
Sort By:
Genes, Chromosomes & Cancer|April 3, 2008
High-resolution analysis of genetic alterations in small bowel carcinoid tumors reveals areas of recurrent amplification and lossMatthew H Kulke, Ellen Freed, Derek Y Chiang, et al.
Cancer Investigation|June 17, 2006
A Phase II trial of vinorelbine in patients with advanced gastroesophageal adenocarcinomaMatthew H Kulke, Alona Muzikansky, Jeffrey Clark, et al.
Journal of Gastrointestinal Cancer|August 20, 2018
Treatment Outcomes in Patients with Metastatic Neuroendocrine Tumors: a Retrospective Analysis of a Community Oncology DatabaseMaxine D Fisher, Sonia Pulgar, Matthew H Kulke, et al.
The Oncologist|January 31, 2020
Treatment Patterns and Health Resource Use Among Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors Treated at a Tertiary Referral CenterJessica J Jalbert, Roman Casciano, Jie Meng, et al.
Pancreas|July 29, 2010
The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomasJonathan R Strosberg, Domenico Coppola, David S Klimstra, et al.
Oncotarget|September 15, 2017
Profiling of metastatic small intestine neuroendocrine tumors reveals characteristic miRNAs detectable in plasmaMichaela Bowden, Chensheng W Zhou, Sui Zhang, et al.
Cancer Investigation|July 1, 2006
A phase II study of doxorubicin, cisplatin, and 5-fluorouracil in patients with advanced adenocarcinoma of the stomach or esophagusMatthew H Kulke, Bingyan Wu, Jeffrey W Clark, et al.
Cancer Investigation|October 21, 2004
A phase II study of docetaxel in patients with metastatic carcinoid tumorsMatthew H Kulke, Haesook Kim, Keith Stuart, et al.
The Journal of Clinical Endocrinology and Metabolism|October 14, 2011
Chromogranin A and neuron-specific enolase as prognostic markers in patients with advanced pNET treated with everolimusJames C Yao, Marianne Pavel, Alexandria T Phan, et al.
The Oncologist|August 7, 2014
Clinical benefits of above-standard dose of octreotide LAR in patients with neuroendocrine tumors for control of carcinoid syndrome symptoms: a multicenter retrospective chart review studyJonathan R Strosberg, Al B Benson, Lynn Huynh, et al.
Pageof 19

Showing results (41-50 of 182) with videos related to

Sort By:
Pageof 19
Genes, Chromosomes & Cancer|April 3, 2008
High-resolution analysis of genetic alterations in small bowel carcinoid tumors reveals areas of recurrent amplification and lossMatthew H Kulke, Ellen Freed, Derek Y Chiang, et al.
Cancer Investigation|June 17, 2006
A Phase II trial of vinorelbine in patients with advanced gastroesophageal adenocarcinomaMatthew H Kulke, Alona Muzikansky, Jeffrey Clark, et al.
Journal of Gastrointestinal Cancer|August 20, 2018
Treatment Outcomes in Patients with Metastatic Neuroendocrine Tumors: a Retrospective Analysis of a Community Oncology DatabaseMaxine D Fisher, Sonia Pulgar, Matthew H Kulke, et al.
The Oncologist|January 31, 2020
Treatment Patterns and Health Resource Use Among Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors Treated at a Tertiary Referral CenterJessica J Jalbert, Roman Casciano, Jie Meng, et al.
Pancreas|July 29, 2010
The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomasJonathan R Strosberg, Domenico Coppola, David S Klimstra, et al.
Oncotarget|September 15, 2017
Profiling of metastatic small intestine neuroendocrine tumors reveals characteristic miRNAs detectable in plasmaMichaela Bowden, Chensheng W Zhou, Sui Zhang, et al.
Cancer Investigation|July 1, 2006
A phase II study of doxorubicin, cisplatin, and 5-fluorouracil in patients with advanced adenocarcinoma of the stomach or esophagusMatthew H Kulke, Bingyan Wu, Jeffrey W Clark, et al.
Cancer Investigation|October 21, 2004
A phase II study of docetaxel in patients with metastatic carcinoid tumorsMatthew H Kulke, Haesook Kim, Keith Stuart, et al.
The Journal of Clinical Endocrinology and Metabolism|October 14, 2011
Chromogranin A and neuron-specific enolase as prognostic markers in patients with advanced pNET treated with everolimusJames C Yao, Marianne Pavel, Alexandria T Phan, et al.
The Oncologist|August 7, 2014
Clinical benefits of above-standard dose of octreotide LAR in patients with neuroendocrine tumors for control of carcinoid syndrome symptoms: a multicenter retrospective chart review studyJonathan R Strosberg, Al B Benson, Lynn Huynh, et al.
Pageof 19